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Protein–protein interactions stabilized by multiple separate hot
spots are highly challenging targets for synthetic scaffolds. Sur-
face-mimetic foldamers bearing multiple recognition segments
are promising candidate inhibitors. In this work, a modular
bottom-up approach is implemented by identifying short fol-
dameric recognition segments that interact with the independ-
ent hot spots, and connecting them through dynamic covalent
library (DCL) optimization. The independent hot spots of
a model target (calmodulin) are mapped with hexameric b-
peptide helices using a pull-down assay. Recognition segment
hits are subjected to a target-templated DCL ligation through
thiol–disulfide exchange. The most potent derivative displays
low nanomolar affinity towards calmodulin and effectively in-
hibits the calmodulin–TRPV1 interaction. The DCL assembly of
the folded segments offers an efficient approach towards the
de novo development of a high-affinity inhibitor of protein–
protein interactions.
Finding synthetic means of targeting protein–protein interac-
tions (PPIs) is a major challenge in chemistry. The class of PPIs
in which a “hot spot pocket” or a contiguous system of con-
served clefts is responsible for binding of the clustered “hot
spot residues” projected from a secondary structure interface
can be inhibited by secondary structure mimetics[1] and small
molecules.[2] It is however inherently difficult to access two or
more separated hot spots that accept residues from a non-
continuous peptide epitope or a flat surface of a globular pro-
tein.[3] PPIs stabilized by symmetrically distributed anchor
points have been targeted by multivalent surface mimetics.[4]
The structurally and enzymatically stable biomimetic foldamers
are among the most promising scaffolds with which to gener-
ate tailor-made protein recognition surfaces and PPI inhibi-
tors.[5] It has been shown for PPIs with single-helix interfaces
that b- and a/b-peptidic foldamers produce excellent structural
mimetics to decouple these interactions. Contiguous hot spot
clusters with structurally complex or uncharacterized interact-
ing partners have also been targeted in top-down backbone
homologation[6] and bottom-up de novo design[7] approaches.
Although the chemical accessibility and the programmable
structure of peptidic foldamers are attractive features, these
scaffolds have not been systematically tested on PPIs with two
or more spatially non-contiguous hot spot pockets. Such a sur-
face-mimetic foldamer can be constructed de novo in a modu-
lar way by finding the secondary structure elements that rec-
ognize the independent hot spots, and by connecting the
binder segments in an optimized combination with a suitable
flexible linker. Here, we set out to test this de novo bottom-up
approach on a protein that displays two separate hot spots. As
a model protein, calmodulin (CaM) was selected, for which N-
and C-terminal EF-hand motifs form the methionine-rich hot
spots that are connected by a flexible region. CaM is a well-
known model for protein recognition and inhibition studies.[8]
In our modular development workflow, we attempted to cap-
ture the canonical protein binding mode of calmodulin with
high affinity, which recognizes a discontinuous epitope, dis-
playing the hydrophobic anchor residues on the opposite
faces of a helix within a distance of 3–5 helical turns (1.5–
2.5 nm).[9]
Our hypothesis was that the target hot spot pockets could
be mapped using short foldameric segments mimicking the
local environment of the hot spot residues in terms of side-
chain presentation and solvent shielding (Figure 1a). In order
to address the problem of simultaneous optimization of the
recognition segments and the linkage, a dynamic covalent li-
brary (DCL) method was deployed (Figure 1b).[10]
The scaffold for the folded segments was chosen to match
the geometrical requirements of a hot spot pocket in general.
It was equipped with protruding proteinogenic side chains
and designed to be sufficiently rigid and bulky to locally ex-
clude the solvent from the binding cleft. A hexameric 14-heli-
cal b-peptide scaffold[11] with a diameter of 10 a fulfilled these
requirements. The structure was stabilized by trans-1,2-amino-
cyclohexane amino acids and projected two proteinogenic
side chains of b3-amino acids from the same face (positions 2
and 5) of the folded helix (Figure 2a). To cover the diverse
chemical characteristics, a 256-membered fragment library was
designed using 16 different b3-amino acids in both positions.
The suitability of b-peptides for constructing structural mimet-
ics for protein recognition has been established,[5a] including li-
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braries generated by using one-bead-one-compound[12] or par-
allel synthesis[13] methods. Here, we utilized a mixture-based li-
brary approach.[14] To simplify the synthesis and analysis,
a total of 256 fragments was divided into four 64-membered
sublibraries (L1–L4, Figure 2a).
It has been noted that careful selection of the DCL compo-
nents is necessary because the correlation between binding ef-
ficiency and amplification might break down in large libraries if
weak binders significantly outnumber the few high-affinity li-
gands.[15] We therefore prefiltered the library members through
an affinity-based pull-down assay, in which the library mem-
bers were incubated with immobilized CaM, and after washing
away the unbound fragments, the CaM–foldamer complexes
were eluted and quantified using HPLC–MS (Figure 2b). Frag-
ments highlighted in bound to CaM, and were almost quanti-
tatively recovered after elution of the protein—foldamer com-
plex. Due to their low affinities, fragments highlighted in blue
were removed by the washing procedure, therefore a small
number of these helices were identified after the final elution.
Foldamers that contained aromatic residues (R1, R2 : W, F; Fig-
ure 2a) in combination with aliphatic side chains were the best
binders, which is consistent with the observation that CaM has
a preference for tryptophan, leucine, and isoleucine resi-
dues.[9, 16] On the basis of relative fragment content (Figure 2b
and Figure S2 in the Supporting Information), one fragment
was selected from each sublibrary for characterization.
The binding of the selected foldameric recognition segment
candidates 1 (R1: W, R2 : F), 2 (R1: R, R2 : W), 3 (R1: L, R2 : W), and
4 (R1: T, R2 : W) (Figure S3) were validated and characterized
quantitatively. Isothermal titration calorimetry (ITC) experi-
ments were performed to identify the thermodynamic parame-
ters of the binding. The measured dissociation constants (Kd)
were 0.076, 0.706, 0.139 and 17.1 mm for 1–4, respectively (Fig-
ure S4). The titration curves could be fitted with a two inde-
pendent sites model and indicated that the target protein
binds uniformly two foldamer segments in these interactions.
The negative DH values for most of the fragments (Figure S4b)
suggested a noncovalent bond complementarity between the
foldameric fragments and the protein,[17] except for 3, for
which a positive enthalpy change was found. For 1, the inter-
action is enthalpy-driven, suggesting that the binding is not
dominated by the hydrophobic interactions, which is an ad-
vantageous characteristic for drug design.
All selected fragments contained a b3-hW residue, which af-
forded the opportunity to measure the blueshift of its side-
Figure 1. The concept of dynamically assembled folded segments. a) Map-
ping of the protein surface by a short folded segment library with protrud-
ing proteinogenic side chains and local solvent shielding. b) Self-sorting of
the folded segments in the presence of the protein target using a dynamic
combinatorial library based on a disulfide-exchange reaction, and selection
of the highest-affinity ligand.
Figure 2. Library of folded segments and mapping of the protein surface
with a pull-down assay. a) Design principle and the sequences of the hex-
americ foldamer library with 16 different amino acids coupled in positions 2
and 5, which resulted in a side-chain display on one face of the 14-helical
structure. A total of 256 compounds were synthesized in four sublibraries
(L1–L4) based on the chemical characteristics of the amino acids in posi-
tion 2. b) Results of the pull-down assay expressed in percentages relative to
the control experiment. Based on HPLC–MS peak integration, relative frag-
ment content was calculated for each library member using the following
formula: (AUCeluted/AUCcontrol)V100, where AUCeluted is the AUC (area under
the curve) of a specific fragment in the eluted fraction and AUCcontrol is the
AUC of the same fragment in the control sample. The color gradient scale
indicates the differences in CaM binding affinity; coloring corresponds to
low (blue) and high (red) abundance of the fragment after elution of the
protein–foldamer complex. Asterisks indicate the segments that exhibited
the highest concentration due to binding in the specific sublibrary. The side
chains of b3-amino acids in positions 2 and 5 are indicated by the standard
a-amino acid one-letter codes. The pull-down assay was repeated three
times, and we did not observe deviation in the results above the experimen-
tal error associated with the HPLC–MS measurements. Here, we show repre-
sentative data from one experiment.
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chain fluorescence emission (from 350 to 330 nm) upon trans-
fer from a solvent-exposed environment to the hydrophobic
clefts of CaM.[18] The blueshift was observed for 1, 2, 3, and 4
(Figure S5). The phenomenon was not detected in the absence
of Ca2+ (removed with EDTA), which confirmed that only the
Ca2+-bound tertiary structure of the protein generates the hot
spot sockets that were recognized by the foldamers. Fluores-
cence titration experiments displayed the same trend of the
binding affinities as those observed by ITC (Figure S6).
The propensity to fold into an H14-helix in aqueous buffer
was confirmed by ROESY experiments on 1–4 (Figure S7); the
long-range i–i+3 inter-residue interactions were detected. To
test the effects of the folding on binding, a non-helical control
derivative of 1 was designed by preventing helix formation
with a non-matching backbone stereochemistry (1R,2R-ACHC)
at position 4 (5, Figure S8).[19] Sequence 5 did not show any
sign of binding and exhibited disorder in water thus support-
ing the necessity of the compact and bulky structure. The af-
finities in the micromolar region for 2 and 4, with their fast ex-
change, afforded transferred NOESY (tr-NOESY) measurements,
which confirmed helical conformations also in the bound state.
(Figure S9) These binding phenomena were not detected in
the absence of Ca2+ (removed from CaM with EDTA, Figure S5),
which confirmed that only the Ca2+-bound tertiary structure of
the protein generates the hot spot pockets that were recog-
nized by the foldamers. We tested the foldamer–CaM interac-
tions with 15N-HSQC NMR spectroscopic titrations, which were
conclusive for 2 and 3 due to sufficient affinity and signal-to-
noise ratio (limited line broadening). Significant chemical shift
perturbation and/or resonance broadening were observed for
target residues L39, M36, M71, M72, M109, M144, and M145
(Figure S10), which are key residues in the CaM–protein con-
tacts and line the hot spot pockets in the N- and C-terminal
EF-hand motifs.[20]
DCLs are attractive tools for the discovery of new ligands for
biomolecules,[10b] and they rely on the reversible generation of
compound mixtures under thermodynamic control. Assem-
bling the fragments with the template in the mixture shifts the
dynamic equilibrium towards the tight binders, thereby in-
creasing the concentration of the high-affinity ligands.[21] The
three best recognition segment candidates were selected from
each sublibrary and synthesized individually with a Gly–Gly–
Cys tag at the C termini (6–17, Figure 3a) to generate the DCL
through a disulfide-exchange reaction.[22] DCLs were prepared
in a glutathione redox buffer in the presence and in the ab-
sence (as a control) of the template. The concentration was
10 mm for each library member. CaM was used as a template at
three concentrations (1, 6 and 30 mm). On the basis of quanti-
tative evaluation with HPLC–MS chromatograms, amplification
factors were determined relative to the control. The DCL mix-
ture reached equilibrium within a reasonably short time[21]
(96 h), and the final reaction mixture contained 12 monomers,
their 12 glutathione adducts and 78 different dimers of the
folded segments (Table S5). The same product distribution was
obtained from different starting mixture compositions (Fig-
ure S11), demonstrating that thermodynamic equilibrium had
been reached. The most amplified dimers contained foldamers
9–11 in combination with sequences 6–8 or 12–14 (Figure 3b).
We found that the presence of positively charged side chains
together with aromatic or aliphatic residues were essential for
the amplification. Despite the quasi-symmetry of CaM, the ho-
modimers of the best binder fragments were not identified,
which points to an emergent feature originating from the sys-
tems chemistry approach. The use of elevated template con-
centrations resulted in increased amplification factors (Fig-
ure 3c and d), but the higher number of enriched heterodim-
ers led to a lower selectivity.[15a,23] The selectivity pattern differ-
ences can be explained by the global behavior of the equili-
brated DCL in response to the multiple molecular-recognition
events facilitated by the higher concentration of the tem-
plate.[24] For the series of ligands in which the dissociation con-
stants of binding to the template are similar, better selectivity
was found at a lower template concentration due to the com-
petition between the building blocks. Accordingly, the DCL
with 1 mm CaM concentration was used for the selection of the
most amplified heterodimer (9-SS-12).
To enhance the synthetic efficiency and avoid a possible in-
stability caused by the disulfide bond in further investigations,
a chemically stable thioether linkage[25] was used to couple the
individual helical segments of 9-SS-12 (18 ; Figure 4a and Fig-
ure S12). ITC characterization revealed a two-step process for
the binding of 18 with the protein (Figure 4b). First, a high-af-
finity binding step was found with a Kd value of 1.54:0.16 nm
(n=1.04), which is a dissociation constant two orders of mag-
nitude lower than that of the monomeric fragments. The 1:1
stoichiometry strongly suggested that we had successfully tar-
geted the separate hot spots on the protein surface with
a single ligand assembled from two folded fragments. The
thermodynamic driving forces for the strong binding were
found to be balanced. The binding enthalpies (DH) were @2.5
and @4.8 kcalmol@1, whereas the entropic contributions
(@TDS) were @9.1 and @7.2 kcalmol@1 at 25 and 35 8C, respec-
tively. Second, a lower-affinity step with a fractional stoichiom-
etry was detected (Figure 4b). This pointed towards the capa-
bility of the helical segments of 18 to interact separately with
both lobes of CaM, which led to crosslinking of the protein by
the ligand at micromolar concentrations. This result was con-
firmed by native gel electrophoresis, indicating multiple types
of complexes after the provision of more than one equivalent
of the foldamer to CaM (Figure S13). Fluorescence titration ex-
periments with 18 revealed a Ca2+-dependent binding to CaM
with a Kd value of 30 nm (Figure S14), which represents an
averaged affinity of the two binding modes.
CaM exerts its Ca2+ sensing function through a number of
PPIs. We selected the CaM–TRPV1 (vanilloid receptor)[26] inter-
action as a model system to test the inhibitory potential of 18.
It has been shown that a 15-mer fragment of the TRPV1 C ter-
minus (TRPV1-CT15) binds CaM with high affinity,
[27] and the X-
ray structure of the complex has been reported.[26] Our ITC
measurements confirmed a Kd value of 30.9:2.1 nm (n=1.02)
(Figure 4c). After saturation of CaM with 2 equivalents of
TRPV1-CT15 in the cell, the titration with 18 resulted in an ap-
parent Kd value of 89.3:12.6 nm for the first step and 1.29:
0.07 mm for the second (Figure 4d). This suggested that the fol-
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dameric ligand can replace TRPV1-CT15 in the first, high-affinity
step of the interaction. In a reverse experimental setup, pre-
binding of 18 to CaM resulted in the blockade of the TRPV1-
CT15–CaM interaction, as indicated by the micromolar apparent
affinity (Figure 4e). ITC experiments were repeated at 35 8C
with similar results (Figure S15). Competitive inhibition was fur-
ther supported by a pull-down assay, in which immobilized
CaM was saturated with TRPV1-CT15 and titrated with 18 at dif-
ferent concentrations, which resulted in elution of TRPV1-CT15
from CaM in a concentration-dependent manner (Figure S16).
In summary, we have shown that a high-affinity synthetic
PPI inhibitor can be developed de novo through the combina-
tion of local surface mimetic foldamer segments and their dy-
namic covalent coupling. This strategy is a synthetically effi-
cient optimization pathway, which could be extended to other




Filtering of the folded fragment library with CaM was performed
by pull-down assay. Cobalt affinity resin suspension (50% w/v,
100 mL; TALON, Takara Bio USA, Inc. , Mountain View, CA) was pipet-
ted into a paper filter spin cup (Thermo Scientific), centrifuged at
1000 rpm for 2 min and washed three times with HEPES buffer
(20 mm, pH 7.4, 300 mL) containing NaCl (150 mm) and CaCl2
(1 mm). Polyhistidine-tagged CaM was conjugated to the resin at
a concentration of 2 mgmL@1, and the mixture was shaken at
100 rpm at room temperature for 30 min. After the conjugation,
Figure 3. Results of the dynamic combinatorial experiments with three different template concentrations. a) Structures of the DCL building blocks. The am-
plification factors measured at thermodynamic equilibrium in the presence of CaM at b) 1 mm, c) 6 mm, and d) 30 mm. The amplification factor is defined as
the ratio of AUCs measured in the presence and the absence of the template. The color scheme indicates the lowest and the highest amplification factors
with blue and red, respectively. “GSH” refers to glutathione adducts.
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the resin was washed three times as described previously to
remove the excess of the protein, and then it was incubated with
the foldamer sublibrary, in which each library member was used at
10 mm concentration. The library with the immobilized CaM was
also shaken at 100 rpm at room temperature for 30 min, and then
it was centrifuged at 1000 rpm for 2 min at room temperature. The
resin was washed three more times following the same procedure
to remove unbound fragments, and freshly prepared imidazole
(200 mm, 200 mL) was added to the sample to elute the polyhisti-
dine-tagged CaM and bound library members from the resin at
room temperature for 5 min. Then, the resin was centrifuged as de-
scribed previously. Negative control experiments were performed
using the same procedure in the absence of polyhistidine-tagged
CaM to measure the nonspecific binding between the resin and
the foldamer library. Eluted fractions and control samples were
measured using HPLC–MS and Thermo Xcalibur 2.2 software was
used for peak identification and integration.
Isothermal Titration Calorimetry Experiments
ITC experiments were performed with a MicroCal VP-ITC microca-
lorimeter. A buffer of HEPES (20 mm, pH 7.0) containing CaCl2
(30 mm) was used. Peptide solutions were sonicated 20 min before
titration to avoid aggregation. Foldamer solution (10 or 15 mL) was
injected from the computer-controlled microsyringe into the CaM
solution at intervals of 240 s. The CaM concentration in the cell
was between 3 and 7 mm, and the concentration of foldamers in
the syringe was 85–200 mm. The temperature was adjusted to 25
or 35 8C. The control experiments were performed by injecting fol-
damers into the cell containing buffer but no target. Experiments
were repeated twice. The experimental data were fitted to the one
binding site or two independent sites model (adjustable parame-
ters: DHb1, Kd1, n1 and DHb2, Kd2, n2) using a nonlinear least-squares
procedure. Errors were calculated by jackknife resampling.
Generation and Analysis of the Dynamic Combinatorial
Library
DCLs were prepared from Gly–Gly–Cys-functionalized building
blocks (6–17) at a concentration of 10 mm in a redox buffer
[pH 7.4, HEPES (20 mm), NaCl (150 mm), CaCl2 ( 1 mm), NaN3
(3 mm) reduced glutathione (GSH, 500 mm) and oxidized gluta-
thione (GSSG, 125 mm)] . CaM was used as a template at 1, 6, and
30 mm, and a control DCL was started in parallel in the absence of
template protein. Libraries were shaken (250 rpm, 37 8C) for five
days in Eppendorf LoBind microcentrifuge tubes. At the beginning
and every 24 h, reaction mixtures (100 mL) were removed for analy-
sis and quenched with 10% TFA in water. All quenched reaction
mixtures were analyzed using HPLC–MS, and library members were
identified according to their mass and hydrophobic characteristics.
Amplification factors were determined as the component concen-
tration ratio relative to the control experiment.
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